Pfizer's move, though, also comes as the industry is undergoing a new wave of reorganizations, years after the biggest players set out to reshape
the way Big Pharma does drug R&D.
Not exact matches
«There are two
ways to receive validation: from partnerships with
big pharma and from smart investors,» Bloom says.
He wasn't surprised that startup CEOs spoke up while the major players did not: «There are a lot more
ways for the Trump administration to hurt
Big Pharma firms with products on the market than there are
ways for the Trump administration to hurt biotech firms.»
And the tactic isn't all that surprising:
big pharma's return on R&D investments has been plummeting over the last decade, and price increases are an easy
way to bolster companies» bottom lines.
Imagine you don't like the
way your physician is imposing his view of the world for you, and worry that his view is unduly influenced by the the marketing dollars of
big pharma.
You can't have it both
ways, either
big pharma is a problem or it isn't.
If you don't have your eye on the prize from the beginning, and work your ass off, and get lucky along the
way, those high - level
big pharma research jobs are a pipe dream.
In practice, since both of the above mentioned therapies are tied up in the slow - moving edifice of
Big Pharma regulatory capture, it will be a long time before they make it to the clinic in any
way that is accessible to an ordinary individual.
And
Big Pharma hasn't yet figured out a
way to turn curcumin into a lucrative pharmaceutical drug.
Once you clear away the junk that's clogging your body from years of poor diet (by the
way, it's not your fault... it's the government,
big pharma, and factory farms), you will unclog your mind as well.
public health humiliation = huge private accumulation (profit)... because a chronic disease «managed» using chronic prescription drugs it's the best
way to make money... but maybe i am a pessimistic guy and
big pharma is really a good entity, they just did their job after all...
Personally, I think if
Big Pharma's vested interest in statin drugs were to get out of the
way, the cholesterol «myth» would be evaluated and resolved correctly.
In this
way, the cosmetic and personal care industry works much like
Big Pharma, using its products to generate repeat business by keeping people trapped in a cycle of symptoms requiring yet another product to treat.
I think that before Van Roekel points fingers at
Big Oil,
Big Pharma and other «
Bigs», he should show us the
way by having «
Big Union» set aside its brazen hypocrisy and start paying its «fair share.»
The latter is expected to accumulate annual «Continuing Medical Education (CME)» credits by reading journal articles, writing quizzes, and attending conferences — and most of the CME courses are funded in a roundabout
way by
Big Pharma.
For UK's
Big Pharma, the loss of EMA is a blow but not a fatal one, they have entities everywhere, they'll find a
way.
The
way the pharmaceutical business model works now, «
big pharma» does not recruit new staff when projects like these come along, but rather, approaches trusted research organisations like ours, or small biotechs that are already set up to hit the ground running.